Literature DB >> 10728679

Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors.

W Jin1, I E McCutcheon, G N Fuller, E S Huang, G J Cote.   

Abstract

Neoplastic transformation of glial cells alters inclusion of the alpha exon in human fibroblast growth factor receptor-1 (FGFR-1) mRNA transcripts. Although normal cells predominantly include the alpha exon, this exon is excluded in most glioblastoma cell transcripts, creating a high-affinity receptor form. In this study, we identified polypyrimidine tract-binding protein (PTB) as a regulator of FGFR-1 splicing. PTB interacted in a sequence-specific manner with the ISS-1 regulatory element in the intron upstream of the a exon. PTB expression was also strongly increased in seven malignant glioblastoma multiforme tumors relative to adjacent normal tissue, but not in a low-grade astrocytoma. These results suggest that increased expression of PTB may contribute to glial cell malignancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728679

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

Review 1.  RNA-protein interactions that regulate pre-mRNA splicing.

Authors:  Ravinder Singh
Journal:  Gene Expr       Date:  2002

2.  Conserved sequence elements associated with exon skipping.

Authors:  Elana Miriami; Hanah Margalit; Ruth Sperling
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

Review 3.  Alternative splicing and cancer metastasis: prognostic and therapeutic applications.

Authors:  Diego M Marzese; Ayla O Manughian-Peter; Javier I J Orozco; Dave S B Hoon
Journal:  Clin Exp Metastasis       Date:  2018-05-29       Impact factor: 5.150

4.  A high-throughput assay to identify small-molecule modulators of alternative pre-mRNA splicing.

Authors:  Ahmet Dirim Arslan; Xiaolong He; Minxiu Wang; Emily Rumschlag-Booms; Lijun Rong; William T Beck
Journal:  J Biomol Screen       Date:  2012-09-12

5.  Mutations in RRM4 uncouple the splicing repression and RNA-binding activities of polypyrimidine tract binding protein.

Authors:  Haiying Liu; Wenqing Zhang; Robyn B Reed; Weiqun Liu; Paula J Grabowski
Journal:  RNA       Date:  2002-02       Impact factor: 4.942

Review 6.  The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression.

Authors:  Asaf Shilo; Zahava Siegfried; Rotem Karni
Journal:  Mol Cell Oncol       Date:  2014-12-01

7.  HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer.

Authors:  Charles J David; Mo Chen; Marcela Assanah; Peter Canoll; James L Manley
Journal:  Nature       Date:  2009-12-13       Impact factor: 49.962

8.  Muscleblind proteins regulate alternative splicing.

Authors:  Thai H Ho; Nicolas Charlet-B; Michael G Poulos; Gopal Singh; Maurice S Swanson; Thomas A Cooper
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

9.  Exon 2 deletion splice variant of gamma-glutamyl carboxylase causes des-gamma-carboxy prothrombin production in hepatocellular carcinoma cell lines.

Authors:  Naoki Ueda; Hidenori Shiraha; Tatsuya Fujikawa; Nobuyuki Takaoka; Yutaka Nakanishi; Mayumi Suzuki; Noriyuki Matsuo; Shigetomi Tanaka; Shin-Ichi Nishina; Masayuki Uemura; Akinobu Takaki; Yasushi Shiratori; Kazuhide Yamamoto
Journal:  Mol Oncol       Date:  2008-06-20       Impact factor: 6.603

10.  Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain.

Authors:  Ian E McCutcheon; Stephen J Hentschel; Gregory N Fuller; Wei Jin; Gilbert J Cote
Journal:  Neuro Oncol       Date:  2004-01       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.